MRCPI, CCST (UK), Director and Senior Interventional Cardiologist, Lead for TAVI and Advanced Device Therapy, Fortis Hospitals, Bannerghatta Road, Bangalore, India
Part 9 of 9 in Detection and Management of Heart Failure: What's to be Done and When to Refer
Building a Heart Failure Clinic: The Model That Standardises Care
May 24, 2026
A dedicated heart failure clinic, in Dr. Singh's assessment, is one of the highest-value investments a cardiology programme can make. At Fortis Bannerghatta Road, new referrals get a full package (pro-BNP, full blood count, renal and liver function, thyroid function, ECG and chest X-ray) before all four pillars of therapy are started together and a dedicated heart failure nurse is assigned with clear instructions on when to recheck renal function and when to bring the patient in urgently.
At every six-monthly or annual review of a stable patient, two tests are non-negotiable: a 12-lead ECG, which tracks the electrical progression of myocardial disease as QRS broadening and eventual bundle branch block, and a pro-BNP, which can flag silent fluid overload before symptoms appear. Patients who remain symptomatic despite optimisation are assessed for CRT and ICD; those who exhaust all device options move to advanced cardiac MRI, biopsy, and formal transplant or LVAD assessment. For those who have exhausted every option, Dr. Singh says it is not wrong to initiate a comfort-focused palliative conversation rather than continued escalation.
This guide is based on a live Jivo Masterclass — Dr. Rajpal Singh taught doctors across Africa on May 24, 2026.
FROM THE LIVE Q&A
Dr. Vaiswa, Uganda
How would you approach severe ascites in a patient with heart failure and liver cirrhosis, with oedema and normal blood pressure?
Dr. Rajpal Singh
This is congestive cardiac failure — combined right and left heart failure — and the patient should ideally be hospitalised for close monitoring of renal function and electrolytes. For NYHA class 3 or 4 patients like this, we now routinely add acetazolamide alongside loop diuretics, which improves diuresis and speeds resolution of congestion as long as renal function isn't severely impaired. If blood pressure is low, low-dose renal-dose dopamine in addition to diuretics can help significantly, particularly with right heart failure and valvular dysfunction. Given the liver cirrhosis, use a higher dose of spironolactone, since it also acts on hepatic ascites, and monitor hepatorenal function closely.
Frequently Asked Questions
What is the risk of recurrent UTI with SGLT2 inhibitors?▼
The mechanism is glycosuria, which is a nidus for genitourinary infections — balanitis in men and UTIs in women, at an incidence of around 5 to 6%. Counsel every patient on personal and perineal hygiene when starting the drug. If a genitourinary infection develops, get a urine culture, and if confirmed, hold the SGLT2 inhibitor until it resolves, then restart with reinforced hygiene counselling.
What is the role of dobutamine in acute heart failure?▼
There is no substantial long-term beneficial role — it is like flogging a dead horse, a transient cardiac output boost without sustained benefit. It's useful only as a short-term emergency bridge for a profoundly hypotensive patient. We now more routinely use noradrenaline rather than dobutamine in acute low-output heart failure.
When should the Sgarbossa criteria not be used?▼
The Sgarbossa criteria identify acute myocardial infarction in the presence of a left bundle branch block, where it is otherwise difficult to tell whether ECG changes represent an acute MI or simply the LBBB pattern — specifically, 4mm or more of ST elevation discordant to the QRS is considered an acute MI regardless of the LBBB. This is used specifically in the context of chest pain with LBBB, not in the context of established heart failure management.
Why do beta blockers initially worsen symptoms before improving survival in heart failure?▼
A failing heart relies on two compensatory mechanisms: increased heart rate and elevated blood pressure. A beta blocker reduces both, so cardiac output falls initially and the patient feels rough — but only for the first one to two weeks. After that, sustained reduction in neurohormonal activation reverses adverse cardiac remodelling and the patient improves steadily. Always counsel patients about this dip in advance and reassure them it will get better; a heart failure nurse is an excellent resource for this kind of communication.
Can BNP be normal in acute heart failure, and how does BNP help distinguish cardiac from respiratory dyspnoea?▼
BNP and NT-proBNP are released in response to myocardial wall stress, so a normal BNP with a normal ECG makes acute heart failure very unlikely as the cause of a patient's breathlessness — the dyspnoea is most likely pulmonary or another non-cardiac cause. One nuance: in a patient presenting late, days after the onset of acute heart failure while partially compensating, BNP can occasionally read lower than expected, so very recent-onset context still matters.
What tests should a new heart failure patient receive at a specialised clinic?▼
A full package before the four pillars of therapy are started together: pro-BNP, full blood count, renal and liver function, thyroid function, a 12-lead ECG and a chest X-ray.
What two tests matter most at a routine heart failure follow-up visit?▼
A 12-lead ECG, which tracks the electrical progression of myocardial disease through QRS broadening and eventual bundle branch block, and a pro-BNP, which can flag silent fluid overload before symptoms return.
What happens if a heart failure patient stays symptomatic despite optimal drug therapy?▼
They are assessed for cardiac resynchronisation therapy and an implantable defibrillator. If they exhaust those options too, the pathway moves to advanced cardiac MRI, biopsy where indicated, and formal transplant or ventricular assist device assessment.
What role does a dedicated heart failure nurse play in this clinic model?▼
The nurse is assigned to each patient with clear instructions on when to recheck renal function and when to bring the patient back in urgently, functioning as the ongoing point of contact between visits.
When is a palliative approach appropriate in heart failure management?▼
Once a patient has exhausted every medical and device option and continues to decline, a comfort-focused conversation is considered appropriate rather than further escalation.
In This Series: Detection and Management of Heart Failure: What's to be Done and When to Refer
- 1.Detection and Management of Heart Failure
- 2.Diagnosing Heart Failure: Why Natriuretic Peptides Come Before the Echo
- 3.The Four Stages of Heart Failure: Catching Patients Before Symptoms Start
- 4.The Four Pillars of Heart Failure Therapy: Starting All Four at Once
- 5.Sacubitril/Valsartan: Why ARNI Has Replaced ACE Inhibitors as First-Line Therapy
- 6.SGLT2 Inhibitors in Heart Failure: A Class 1A Drug Regardless of Diabetes Status
- 7.Drugs to Avoid in Heart Failure: Calcium Channel Blockers, NSAIDs and DPP-4 Inhibitors
- 8.When to Refer for ICD, CRT, LVAD or Transplant in Advanced Heart Failure
- 9.Building a Heart Failure Clinic: The Model That Standardises Care